Public Procurement Access for Medical Devices in Belarus

1. Key takeaways

The Belarusian medical market is dominated by procurement funded from the state budget, and the threshold to the public segment is the twin condition of registration plus access. Completing registration alone, without addressing price registration and procurement access requirements, rarely produces actual sales. The reason is structural: the purchasing entities are public healthcare institutions operating under budget rules, and budget rules demand documentation and status that commercial buyers never ask for. A product therefore needs to be not only lawful but procurement-ready — registered, price-registered and able to pass the purchaser’s access checks. Companies that model their Belarus revenue on the share of demand that runs through public channels should treat the three conditions as one workstream with one calendar, because each condition gates the next: no registration means no lawful circulation, no price registration means no tender participation, and no access file means the tender cannot be won even with the first two in hand. Planning them in sequence, with named owners and dates, is the practical way to keep the three from drifting apart.

2. Legal basis

Each row maps to one stage of the public market path. Resolution No. 211 establishes registration as the precondition for lawful circulation, which is the first gate. Resolution No. 378 relocates price registration to Gosfarmnadzor from 2026-07-30, defining which institution manages the second gate. Resolution No. 177 sets the circulation rules that apply once the product moves commercially, and Article 39-1 of the Healthcare Law anchors the entire regime. Read together, they describe the legal skeleton over which the registration, price and access stages are built.

3. Expert insights

Insight one: the market structure determines where compliance effort belongs. The Belarusian healthcare system is financed principally from the state budget, and public medical institutions are the main purchasers. Compliance work therefore cannot stop at obtaining the registration certificate; it must extend to the documents and registration statuses that purchasers demand. A certificate that satisfies the regulator may still leave a tender documentation gap, and discovering that gap during a tender window is the most expensive way to find it. Mapping the purchaser’s document expectations at project start converts the access stage from improvisation into checklist work.

Insight two: registration, price registration and procurement access form a three-stage sequence. Registration establishes the lawful circulation status; price registration establishes the compliant price level; procurement access determines whether purchasers will accept the product. The stages advance one after another, and a gap at any stage blocks sales. Treating them as parallel workstreams is the commonest planning error: teams file the registration, defer the price work and discover at tender time that the price file takes months, not weeks, because the liaison institution changed on 2026-07-30 and the internal process never caught up.

Insight three: the importance of a local partner is amplified in the public market. In a market driven by state budget procurement, cooperation with the state distribution system is often the practical precondition for reaching the channel. When selecting partners, companies should assess public channel coverage, not only registration handling capability. A partner who can file a competent dossier but has no standing with public purchasers delivers a certificate without sales, which in a budget-funded market is a strategic dead end rather than a launch.

Insight four: regulatory dynamics affect continuity of access. No. 211 (2026-05-01) and No. 378 (2026-07-30) made two successive adjustments, changing respectively the registration rules and the attribution of price registration and adverse event functions. Companies in long-term procurement should establish a quarterly tracking mechanism for regulatory developments, so that access status is not interrupted by rule changes arriving mid-contract. A long supply agreement signed without a regulatory review clause inherits every such change silently, with the risk landing entirely on the supplier.

4. Practical recommendations

The recommendations below structure access as a managed sequence rather than a series of separate tasks.

1. Plan access in three stages. Assign a responsible owner and a date to each of registration, price registration and procurement access, so the sequence is explicit and no stage is left unowned.
2. Bring regulatory dynamics into procurement contract management. Include a review clause for regulatory changes in long-term supply agreements, so rule changes trigger a documented reassessment rather than silent exposure.
3. Assess partners on public channel capability. Make public channel coverage a core selection criterion for distribution partners, ahead of generic regulatory experience.
4. Run quarterly regulatory tracking. Focus the tracking on subsequent amendments to No. 211 and No. 378, since those two instruments govern the stages that gate public sales.

5. Verification checklist

• □ Dates have been set for each of the three stages: registration, price registration and procurement access
• □ Long-term supply agreements include a review clause for regulatory changes
• □ Partners have been assessed on public channel coverage capability
• □ A quarterly regulatory tracking mechanism has been established
• □ A compliance impact assessment of No. 211 and No. 378 has been completed

Regulatory information verified as of 30 October 2026.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities on three areas. First, distinguishing between the applicability conditions and the remaining time windows of the two channels, the Union-wide registration and the national registration of each member state — the national registration procedure of Belarus has been fully re-routed by the Council of Ministers Resolution No. 211 of 28 April 2026 (state register number 6-1/55925, effective 2026-05-01), which compresses the total timeframe for preliminary technical work to 90 calendar days, keeps the list of such work closed, and prohibits the implementing organisation from expanding it, while the window for submitting applications under the national procedure takes 2027-12-31 as its key milestone, so route selection must be decided in step with the time window. Second, local authorised representative services: GRZAN can act as the statutory representative of a manufacturer in Belarus, undertaking registration submission, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison mechanisms after the Council of Ministers Resolution No. 378 of 27 July 2026 (effective 2026-07-30) transferred adverse event functions to the state agency State Pharmaceutical Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and organises technical documentation according to the target route — for the national route, per the annexes to Ministry of Health Resolution No. 55; for the Union route, per EEC Council Decision No. 46.

For business enquiries: info@grzanglobal.com